Clever Leaves Holdings Inc.
CLVRW
NASDAQ Capital Market0.03
USD
- -
- -
Clever Leaves Holdings Inc.
CLVRW
(NASDAQ Capital Market)
Recent
price
0.03
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Clever Leaves Holdings Inc. operates as a multinational producer of pharmaceutical-grade cannabinoids and nutraceutical products, focusing on cultivation, extraction, manufacturing, and distribution of medical cannabis and related wellness items. The company offers core cannabinoid products including dried cannabis flowers, cannabidiol (CBD) isolates, full spectrum and standardized extracts, dry smokable flowers, oral solutions, and tetrahydrocannabinol (THC) formulations; its non-cannabinoid segment provides nutraceutical remedies, wellness products, detoxification items, and nutritional supplements sold to mass retailers, specialty health outlets, and distributors primarily in the United States. Products adhere to EU Good Manufacturing Practice (GMP) standards and Good Agricultural and Collection Practices (GACP), with operations centered in Colombia's large-scale greenhouses and certified extraction facilities capable of processing over 104,000 kilograms of dried flower annually, expanding to 324,000 kilograms. Clever Leaves serves pharmaceutical companies, cannabis firms, pharmacies, and retail distributors in regulated medical cannabis markets such as Germany, Australia, Brazil, Israel, Mexico, and over 15 countries worldwide through export shipments for commercial and research purposes. Founded in 2017 and headquartered in Tocancipá, Colombia, the company maintains a global footprint with prior facilities in Portugal and strategic commercial partnerships including supply agreements with Cannatrek and IDT Australia for white label products, GreenCare in Brazil for licensed distribution, and CBD Life Holding in Mexico for active pharmaceutical ingredients. Recent developments include the March 2024 sale of its Herbal Brands subsidiary to KAC Investments LLC for $8 million to streamline operations and recognize a gain; voluntary delisting from Nasdaq and termination of SEC reporting obligations in May 2024 to reduce regulatory costs and compliance burdens; wind-down of Portugal operations in 2023 as part of a restructuring plan initiated in January 2023 to enhance margins; divestiture of its Cansativa stake in Germany for approximately $1.9 million in 2023; and ongoing financial restructuring efforts amid a shift to OTC trading under CLVR and CLVRW. These changes position Clever Leaves to prioritize cost-efficient Colombian production, cannabinoid revenue growth—up 39% in 2023—and expansion in high-demand international markets while managing operational challenges.